Company LexaGene Holdings Inc. Toronto S.E.
Equities
LXG.H
CA52886L1031
Biotechnology & Medical Research
Business Summary
Number of employees: 33
Managers
Managers | Title | Age | Since |
---|---|---|---|
Jack Regan
CEO | Chief Executive Officer | - | 07-04-25 |
Jeffrey Mitchell
DFI | Director of Finance/CFO | - | 18-02-28 |
Steven Armstrong
COO | Chief Operating Officer | - | 20-03-23 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Joseph P. Caruso
BRD | Director/Board Member | 65 | 18-06-17 |
Jack Regan
CEO | Chief Executive Officer | - | 07-04-25 |
Tom Slezak
BRD | Director/Board Member | - | 16-10-11 |
Jane Sykes
BRD | Director/Board Member | - | 21-11-14 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 140,740,255 | 115,621,362 ( 82.15 %) | 0 | 82.15 % |
Company contact information
Lexagene Holdings, Inc.
500 Cummings Center Suite 4550
01915, Beverly
+800 215 1824
http://www.lexagene.comSector
1st Jan change | Capi. | |
---|---|---|
-6.65% | 12.14B | |
+82.29% | 3.94B | |
-14.23% | 2.32B | |
-23.73% | 2.19B | |
-19.45% | 1.63B | |
+32.37% | 1.14B | |
+7.42% | 852M | |
-11.75% | 545M | |
-34.49% | 419M |